COVID-19: The situation in Peru and managing radiotherapy patients
Dr. Gustavo Sarria – Presidente en Sociedad de Radioterapia del Peru, Lima, Peru
17 Apr 2020
The age of genomic profiling
Prof Cengiz Yakicier - Acıbadem University, Istanbul, Turkey
27 Jan 2020
HER2CLIMB: Investigating tucatinib with capecitabine and trastuzumab in HER2-pos...
Dr Rashmi Murthy - MD Anderson Cancer Center, Houston, USA
23 Jan 2020
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
30 Sep 2019
Important developments in radiation oncology
Dr Ana Botero - Memorial Healthcare System, Hollywood, FL, USA
26 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain me...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
Are PARP inhibitors a new standard of care option for MBC patients?
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
18 Jun 2019
Potential of PARP inhibitors for metastatic breast cancer
Dr Alexandra Zimmer - National Cancer Institute, Bethesda, USA
3 Jun 2019
Artificial intelligence and treatment decisions
Dr Pratik Shah - Massachusetts Institute of Technology, Cambridge, USA
24 May 2019
CNS involvement and prophylaxis in acute lymphoblastic leukaemia
Dr Mark Litzow - Mayo Clinic, Rochester, USA
24 May 2019
Future directions in glioblastoma: the potential role of TKIs
Prof Roger Stupp, Dr Giuseppe Lombardi
9 May 2019
